H.C. Wainwright & Co., LLC’s Post

Clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access. In this article from the Journal of mHealth, Natalie Yeadon explores a few of these, along with how getting early and timely feedback from all relevant stakeholders can help prevent them from occurring or minimize their impact. https://hubs.la/Q020Vztq0

Clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access. In this article from the Journal of mHealth, Natalie Yeadon explores a few of these, along with how getting early and timely feedback from all relevant stakeholders can help prevent them from occurring or minimize their impact. https://hubs.la/Q020VtZb0

Access to essential medicines is a fundamental component of global health security and well-being. Yet, numerous barriers—stemming from both market dynamics and governmental policies—often hinder the seamless delivery of these vital resources to the people who need them most. At The Gryphon Group, we are deeply committed to understanding and addressing these challenges. In our most recent blog post, we will explore both challenges and solutions, with an eye toward the current conversation in Canada about a national pharmacare plan. 🔗 Learn more: https://lnkd.in/gXSzvQFq #medicineaccess #medicalcare #canadianhealth #canadianhealthcare #patientcenteredcare #TheGryphonGroup

In this engaging case study, discover how Kootenai Health overcame challenges and deepened their relationship with Mayo Clinic Laboratories to launch an in-house reference lab. Read more. https://bit.ly/3ztvAAE

🌟 Day 2 at the European Congress on Obesity is buzzing! 🌟 From enlightening lectures to engaging discussions, it is a day filled with valuable insights and connections. 💬 We have lots of activity in the booth, with many participants stopping by to learn more about the Yazen model. It is heartening to see so many passionate individuals coming together to address the obesity challenge. We have put together a summary of a few of the highlights from yesterday’s lectures, presented by Martin Carlsson, Chief Medical Officer, and Elin Skoglund, Head of Clinical Operations at Yazen.  #Yazen #YazenHealth #ECO2024 #ObesityAwareness #ObesityTreatment #EuropeanCongressOnObesity

Partner with the globally esteemed foundation acknowledging progress benefiting human health. Learn more about how a partnership with the Galien Foundation can help to bridge borders, traverse new policies stemming disease, and save lives: https://lnkd.in/ehmHAi3n

📰 We have interesting factsheets for key stakeholders! Discover the latest #HumanMicrobiomeAction factsheets designed for various stakeholders in microbiome science and beyond. 🦠 Whether you're a #healthcare practitioner, a #policymaker, or a #industry specialist, explore the fascinating world of microbiome science. ⚕️⚖️🔬 Explore the fascinating world of your microbiome by reading these informative articles 👇 Meanwhile, mark your calendars for our upcoming final conference! Register here to secure your spot, engage with experts and participate in this enlightening experience 🎟️ ⏩ https://lnkd.in/eXyszcBe

The Food as Medicine Summit started today! If you are in Chicago and want to learn more about how data-driven insights fit into the conversation, say hi 👋 to Leora Ross, MPH. Check out the full agenda here: https://hubs.la/Q02x_nJH0 #foodasmedicinesummit #foodasmedicine #SDoH

Congratulations to Elena L. and team (Reham Aldakhil, Geva Greenfield, Hadar Zaman, Azeem Majeed, Benedict Hayhoe) on the protocol paper recently published in BMJ Open. This systematic review aims to bridge this gap by assessing the effectiveness of structured medication reviews (SMRs) in improving outcomes for adults with multimorbidity and polypharmacy in primary care. A secondary objective is to examine how the mode of delivery of SMRs (remote vs face-to-face) impacts outcomes.

The Institute is focused on identifying strategies to reduce drug costs for public sector employees, retirees, and their families. Dive into our white paper How Public Sector Health Care Purchasers are Addressing Rising Drug Costs to see how purchasers are navigating rising costs. Visit our website: https://lnkd.in/eMkhEDd5